Ledger.Open graph →
SEC Form D · Amendment · filed September 27, 2017

Sofregen Medical Inc

Offering
$9.7M
Sold
$9.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Doug Sheldon · Medford, MADirectorAnh Hoang · Medford, MAExecHoward Weisman · Cambridge, MAExec · DirectorAmir Nashat · Cambridge, MADirectorMilan Kofol · Medford, MAExecDoug Sheldon · Medford, MADirectorAnh Hoang · Medford, MAExecHoward Weisman · CAMBRIDGE, MAExec · DirectorAmir Nashat · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗